144
0001689575
XXXXXXXX
LIVE
0001818331
GeneDx Holdings Corp.
001-39482
333 Ludlow St, North Tower
6th Floor
Stamford
CT
06902
8887291206
Katherine Stueland
Officer
Director
Class A Common Stock
Morgan Stanley Smith Barney
2000 Westchester Avenue
Purchase
NY
10577
94495
9268700
28904590
01/29/2026
NASDAQ
Class A Common Stock
05/02/2022
Acquired as compensation - Restricted Stock Units
Issuer
N
1653
05/02/2022
Compensation
Class A Common Stock
03/15/2025
Acquired as compensation - Performance-based Restricted Stock Units
Issuer
N
26847
03/15/2025
Compensation
Class A Common Stock
12/09/2022
Acquired as compensation - Restricted Stock Units
Issuer
N
3686
12/09/2022
Compensation
Class A Common Stock
03/15/2025
Acquired as compensation - Restricted Stock Units
Issuer
N
6712
03/15/2025
Compensation
Class A Common Stock
04/26/2023
Acquired as compensation - Restricted Stock Units
Issuer
N
10557
04/26/2023
Compensation
Class A Common Stock
03/26/2024
Acquired as compensation - Restricted Stock Units
Issuer
N
45040
03/26/2024
Compensation
N
Katherine Stueland
333 Ludlow St, North Tower
6th Floor
Stamford
CT
06902
Class A Common Stock
10/29/2025
2158
294654
Katherine Stueland
333 Ludlow St, North Tower
6th Floor
Stamford
CT
06902
Class A Common Stock
12/09/2025
3639
579620
Katherine Stueland
333 Ludlow St, North Tower
6th Floor
Stamford
CT
06902
Class A Common Stock
12/16/2025
10857
1562217
Represents approximately 94,495 shares to be sold on behalf of the Reporting Person, including 1) 1,653 shares to be sold in connection with vesting of RSUs on January 29, 2026; 2) approximately 26,847 shares to be sold in connection with anticipated vesting of PRSUs on or around March 3, 2026; 3) approximately 3,686 shares to be sold in connection with anticipated vesting of RSUs on March 9, 2026; 4) approximately 6,712 shares to be sold in connection with anticipated vesting of RSUs on March 15, 2026; 5) approximately 10,557 shares to be sold in connection with anticipated vesting of RSUs on March 16, 2026; and 6) approximately 45,040 shares to be sold in connection with anticipated vesting of RSUs on March 26, 2026. Shares sold in the past 3 months by the Reporting Person include 16,654 shares sold to cover tax withholding obligations in connection with vesting and settlement of RSUs.
01/29/2026
/s/ Katherine Stueland